Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-24 @ 5:39 PM
NCT ID:
NCT04012268
Eligibility Criteria:
Inclusion Criteria:
* Age: 18-60 years
* All of the patients underwent digital subtraction angiography (DSA) and met the current diagnostic criteria recommended by the Research Committee on MMD of the Ministry of Health and Welfare of Japan in 2012.
* mRs≤3
* Informed consent obtained from patient or acceptable patient's surrogate.
Exclusion Criteria:
* Patients with acute ischemic or hemorrhagic stroke within 3 months.
* Severe hepatic or renal dysfunction.
* Severe hemostatic disorder or severe coagulation dysfunction.
* Severe cardiac diseases.
* Patients with severe existing neurological or psychiatric disease
* Patients with moyamoya syndrome caused by autoimmune disease, Down syndrome , neurofibromatosis, leptospiral infection, or previous skull-base radiation therapy.
* Patients have been done or plan to accept revascularization surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04012268
Study Brief:
Protocol Section:
NCT04012268